RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 67-77
  • Company denies rat poison in pills linked to India sterilization deaths

    Company denies rat poison in pills linked to India sterilization deaths
    The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison. Preliminary tests...
  • AbbVie's new hepatitis C treatment gets approval in EU

    AbbVie's new hepatitis C treatment gets approval in EU
    Drugmaker AbbVie Inc. said Monday that its new, all-pill hepatitis C combo treatment has been approved for patients in the 28 European Union member countries. The company said the European Commission granted marketing authorization for the combination...
  • Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

    Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
    A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals...
  • Baxter seeks OK to sell new hemophilia drug

    Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug. The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    Valeant says it's willing to raise offer for Allergan to $200 a share
    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • Allergan seeks to bar Bill Ackman from voting amid takeover bid

    Attorneys for Botox maker Allergan Inc. asked a federal judge in Santa Ana on Tuesday to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. At issue is a $50-...
  • Allergan says a 2nd suitor wants to buy it, adding to takeover drama

    Allergan says a 2nd suitor wants to buy it, adding to takeover drama
    Botox maker Allergan Inc., which has been fighting an unsolicited takeover bid from a Canadian pharmaceutical maker for six months, said in a regulatory filing that a second company is interested in buying it. Allergan did not identify the new...
  • Oklahoma Supreme Court puts abortion restriction on hold

    The Oklahoma Supreme Court on Tuesday temporarily put on hold a state law restricting abortions while the issue is argued in a lower court. The unanimous action by the high court means that women in Oklahoma can continue to use the prescription drugs...
  • Allergan loses bid to block Ackman from voting on takeover

    Allergan loses bid to block Ackman from voting on takeover
    Botox maker Allergan Inc. lost its bid to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. Allergan had accused Ackman's Pershing Square Capital Management...
  • OraSure expects milestones in its Ebola research

    OraSure expects milestones in its Ebola research
    By the end of the year, Bethlehem-based OraSure expects to announce key research milestones in determining if its OraQuick rapid in-home HIV test can be adapted to screen patients for Ebola. The company has consulted with the federal Food and Drug...